Purchase Order 75N91022P00591
Award Date 8/1/22
Potential Completion Date 7/31/24
Potential Value $65K
Federal Agency
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Jose, CA 95131, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for maintenance services on two BD LSR Fortessa SORP flow cytometers. The contract has a base period of performance from April 17, 2021 through April 16, 2022, with four 12-month option periods, for a total potential value of $80,838. The contract does not have a set-aside designation. BD is a large, for-profit...
- This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for maintenance and support services for a BD LSR Fortessa flow cytometry instrument and associated instrumentation. The contract has a base period from August 1, 2021 to July 31, 2024, with a ceiling value of $73,900.44. The contract was awarded competitively without a set-aside designation, indicating...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed-price purchase order to Becton, Dickinson and Company (BD), a global medical technology company, for preventive maintenance, emergency service, support, and coverage for four government-owned BD Biosciences flow cytometry instruments. The one-year contract with four option years, valued at $148,833.48, provides for semi-annual preventive maintenance, on-site emergency repair...
- This is a $93,978.96 firm fixed-price purchase order awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for maintenance services on a BD FACSymphony A5 flow cytometer and associated instrumentation. The contract is for a base period ending on March 31, 2024, with no set-aside designation. The contract was awarded without competition under simplified acquisition procedures for commercial items, as the NCI...
- This is a firm fixed-price purchase order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for the pre-contract inspection of a BD LSRFortessa 4B/2R/2UV 3 laser flow cytometry instrument. The $15,000.00 contract does not have a set-aside designation, reflecting BD's competitive position as a large, established manufacturer of medical technologies and laboratory equipment. The LSRFortessa instrument is...
- This is a $1,994,840.77 firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) through its BDB Division and BD Biosciences brand. The contract is for maintenance services on various government-owned BD flow cytometry equipment over the base period ending on July 1, 2026. BD is a global medical technology company that specializes in flow cytometry, cell imaging, and...
- This is a firm-fixed price purchase order for maintenance and repair services on six BD Biosciences flow cytometry instruments owned by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The $257,078.10 contract was awarded to Becton, Dickinson and Company (BD), the original manufacturer and sole authorized service provider for the specialized instruments. The services include preventative maintenance,...
- The National Cancer Institute (NCI), a component of the National Institutes of Health under the Department of Health and Human Services, awarded a firm fixed-price purchase order to Becton, Dickinson and Company (BD), through its BD Biosciences division, for preventive maintenance services on a government-owned BD LSRFortessa Flow Cytometer. This contract, valued at $144,941.40, represents the exercise of Option Period One under the original maintenance agreement and extends through August 31,...
- This is a firm fixed-price purchase order awarded by the National Cancer Institute (NCI) of the National Institutes of Health (NIH) to Becton, Dickinson and Company (BD) for preventive maintenance services on a BD Biosciences FACSLyric flow cytometer with a universal loader. The total ceiling value of the contract is $126,468.00 and it includes a 1-year base period and four 1-year option periods, with services to be performed on-site at the NCI's facility in Bethesda, Maryland. As the original...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) to Becton, Dickinson and Company (BD) for maintenance services on a government-owned BD Influx cell sorter at the National Cancer Institute's (NCI) Center for Immuno-Oncology (CIO) Flow Cytometry Core. The $50,194.80 contract covers one year of preventive maintenance, unlimited remote technical support, and unlimited on-site emergency repairs. This sole-source award from August 2024 to July 2025 has...